Register entry
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 3
- Shortage listings
- 1
- Countries
- 0
Alert
Drug shortage listings
1| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Vigabatrin Oral SolutionNeurology | Vigpoder, Oral Solution, 50 mg/1 mL (NDC 80789-117-50) | To Be Discontinued | - | 16 Oct 202516 Oct 2025 |
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12016857 | VIGAFYDEvigabatrin | product | Aug 2039 |
| 12290499 | VIGAFYDEvigabatrin | product | Oct 2042 |
| 12576054 | VIGAFYDEvigabatrin | product | Jun 2043 |
Enquiry
Common questions
- Is PYROS PHARMACEUTICALS INC FDA approved?
- PYROS PHARMACEUTICALS INC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.